TRI - TEVA

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL AS FUMARATE

Dostupno od:

ABIC MARKETING LTD, ISRAEL

ATC koda:

J05AR06

Farmaceutski oblik:

FILM COATED TABLETS

Sastav:

EFAVIRENZ 600 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL AS FUMARATE 245 MG

Administracija rute:

PER OS

Tip recepta:

Required

Proizveden od:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Područje terapije:

EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ

Terapijske indikacije:

TRI-TEVA is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.

Datum autorizacije:

2020-01-16

Uputa o lijeku

PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed with a doctor’s prescription only
TRI-TEVA
Coated tablets
COMPOSITION:
Active ingredients:
Each coated tablet contains:
Efavirenz 600 mg
Emtricitabine 200 mg
Tenofovir disoproxil (fumarate) 245 mg
For information regarding inactive ingredients, see section 2
“Important information
about some ingredients of the medicine” and section 6 “Additional
information”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This
leaflet contains
concise information about the medicine. If you have additional
questions, refer to the
doctor or the pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may harm
them even if it seems to you that their medical condition is similar.
Tri-Teva is intended for use by adults, from 18 years old and older.
The medicine has
not been studied in children under 18 years of age or in adults above
65 years of
age.
1.
WHAT IS THE MEDICINE INTENDED FOR?
Tri-Teva can be used by itself as a full treatment, or in combination
with other
antiretroviral medicines, for treatment of HIV-1 infection in adults.
The HIV virus destroys CD4+ T cells, which are important for the
immune system.
The immune system helps fighting infections. After a large number of T
cells is
destroyed, an Acquired Immune Deficiency Syndrome (AIDS) develops.
Tri-Teva helps to block the HIV-1 reverse transcriptase enzyme, which
is a viral
chemical that is found in the body and is required for the
multiplication of HIV-1.
Tri-Teva reduces the amount of HIV-1 in the blood (viral load).
Tri-Teva may also
help increase the number of T cells (CD4+ cells), thereby improving
the function of
the immune system. Reducing the amount of HIV-1 in the blood reduces
the risk for
death or for infections that occur when the immune system is weak
(opportunistic
infections).
Tri-Teva does not cure a HIV-1 infection or AIDS, and you may continue
to
experience illnesses that are related to